Similar articles for PMID: 30422890

Year	Number of Results
2001	1
2008	1
2009	1
2011	1
2012	3
2013	7
2014	4
2015	11
2016	9
2017	17
2018	15
2019	10
2020	19
2021	8
2022	7
2023	4
2024	0

1

An Orally Available NLRP3 Inflammasome Inhibitor Prevents Western Diet-Induced Cardiac Dysfunction in Mice.

Carbone S, Mauro AG, Prestamburgo A, Halquist MS, Narayan P, Potere N, Mezzaroma E, Van Tassell BW, Abbate A, Toldo S. Carbone S, et al. J Cardiovasc Pharmacol. 2018 Dec;72(6):303-307. doi: 10.1097/FJC.0000000000000628. J Cardiovasc Pharmacol. 2018. PMID: 30422890 Free PMC article.

2

Interleukin-18 mediates cardiac dysfunction induced by western diet independent of obesity and hyperglycemia in the mouse.

Carbone S, Lee PJ, Mauro AG, Mezzaroma E, Buzzetti R, Van Tassell B, Abbate A, Toldo S. Carbone S, et al. Nutr Diabetes. 2017 Apr 10;7(4):e258. doi: 10.1038/nutd.2017.1. Nutr Diabetes. 2017. PMID: 28394363 Free PMC article.

3

A high-sugar and high-fat diet impairs cardiac systolic and diastolic function in mice.

Carbone S, Mauro AG, Mezzaroma E, Kraskauskas D, Marchetti C, Buzzetti R, Van Tassell BW, Abbate A, Toldo S. Carbone S, et al. Int J Cardiol. 2015 Nov 1;198:66-9. doi: 10.1016/j.ijcard.2015.06.136. Epub 2015 Jul 2. Int J Cardiol. 2015. PMID: 26151718

4

Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice.

Bostick B, Habibi J, DeMarco VG, Jia G, Domeier TL, Lambert MD, Aroor AR, Nistala R, Bender SB, Garro M, Hayden MR, Ma L, Manrique C, Sowers JR. Bostick B, et al. Am J Physiol Heart Circ Physiol. 2015 May 1;308(9):H1126-35. doi: 10.1152/ajpheart.00898.2014. Epub 2015 Mar 6. Am J Physiol Heart Circ Physiol. 2015. PMID: 25747754 Free PMC article.

5

The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice.

Gao RF, Li X, Xiang HY, Yang H, Lv CY, Sun XL, Chen HZ, Gao Y, Yang JS, Luo W, Yang YQ, Tang YH. Gao RF, et al. Int Immunopharmacol. 2021 Jan;90:107133. doi: 10.1016/j.intimp.2020.107133. Epub 2020 Nov 7. Int Immunopharmacol. 2021. PMID: 33168408

6

Preservation of Contractile Reserve and Diastolic Function by Inhibiting the NLRP3 Inflammasome with OLT1177^® (Dapansutrile) in a Mouse Model of Severe Ischemic Cardiomyopathy Due to Non-Reperfused Anterior Wall Myocardial Infarction.

Aliaga J, Bonaventura A, Mezzaroma E, Dhakal Y, Mauro AG, Abbate A, Toldo S. Aliaga J, et al. Molecules. 2021 Jun 9;26(12):3534. doi: 10.3390/molecules26123534. Molecules. 2021. PMID: 34207886 Free PMC article.

7

SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor.

Ye Y, Bajaj M, Yang HC, Perez-Polo JR, Birnbaum Y. Ye Y, et al. Cardiovasc Drugs Ther. 2017 Apr;31(2):119-132. doi: 10.1007/s10557-017-6725-2. Cardiovasc Drugs Ther. 2017. PMID: 28447181

8

A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet.

Yang G, Lee HE, Lee JY. Yang G, et al. Sci Rep. 2016 Apr 14;6:24399. doi: 10.1038/srep24399. Sci Rep. 2016. PMID: 27075683 Free PMC article.

9

Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice.

Aroor AR, Habibi J, Kandikattu HK, Garro-Kacher M, Barron B, Chen D, Hayden MR, Whaley-Connell A, Bender SB, Klein T, Padilla J, Sowers JR, Chandrasekar B, DeMarco VG. Aroor AR, et al. Cardiovasc Diabetol. 2017 May 5;16(1):61. doi: 10.1186/s12933-017-0544-4. Cardiovasc Diabetol. 2017. PMID: 28476142 Free PMC article.

10

Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK-mTOR Interplay.

Chen H, Tran D, Yang HC, Nylander S, Birnbaum Y, Ye Y. Chen H, et al. Cardiovasc Drugs Ther. 2020 Aug;34(4):443-461. doi: 10.1007/s10557-020-06978-y. Cardiovasc Drugs Ther. 2020. PMID: 32335797

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year